GLAND PHARMA Ltd IPO Review (Gland Pharma IPO), Dates, Price Bands, Market Lot, Gland Pharma IPO Grey Market Price, Listing Date & Time Details
Let’s have a detailed review of the company and analytics of the Gland Pharma Limited IPO release date, IPO offer price, subscription, Gland Pharma IPO allotment, grey market price and other details like the company’s background, its financial positions, its promoters and other related things.
Gland Pharma Limited launch IPO in November, to raise Rs 6500 crore. The initial public offer (IPO) of Gland pharma limited is expected to be launched on November 2020.
Hyderabad-based Gland Pharma is set to launch its maiden initial public offer on November 9 to raise about Rs 6,500 crore. The price band for the offer has been fixed at Rs 1,490-1,500 per share. The issue will close on 11 November.
Gland Pharma gets Sebi approval for Rs 6,500-crore IPO, set for first listing of an Indian firm with a Chinese parent. The IPO is a mixture of primary and secondary issue of shares with both China’s Fosun group and the founders of Gland Pharma due to dilute shares. Gland Pharma launch the IPO in November 2020.
Source:- https://www.moneycontrol.com/news/business/ipo/gland-pharma-gets-sebi-approval-for-rs-6000-crore-ipo-set-for-first-listing-of-an-indian-firm-with-a-chinese-parent-5995831.html
About Gland Pharma
Gland Pharma one of the fastest-growing generic injectables-focused companies by revenue in the United States from 2014 to 2019 (Source: IQVIA Report). They are present in sterile injectables, oncology, and ophthalmics, and focus on complex injectables, NCE-1s, First-to-File products, and 505(b)(2) filings.
Gland Pharma is typically a B2B company. Generic injectable are bio-equivalent of their branded counterparts which are not protected by drug patents. They are as safe and effective as the innovator drugs since they have similar active ingredients, dosage, strength, quality, form, etc.
A series of IPOs have been launched in recent months. but no pharma company has listed on the Indian bourses this year. The last IPO by an Indian drug maker—Eris Lifesciences— was more than three years ago in June 2017. The offer is likely to comprise a fresh issue aggregating up to Rs 1,250 crore and an offer for sale of up to Rs 4,750 crore.
Gland Pharma IPO – Issue Details:
| Issuer | Gland Pharma Ltd. | |
| Issue Type | Book Built Issue IPO | |
| Issue Period | Issue Opens: November 9, 2020 | |
| Issue Closes: November 11, 2020 | ||
| Price Brand | ₹ 1490 – 1500 (Tentative) Equity share | |
| Issue Size | ₹6500 Crores (Approx.) | |
| Face Value | Rs.1 per Equity Share | |
| Market Lot | 10 Shares and in multiples thereof | |
| Maximum Bid amount for Retail | Rs. 2 Lakhs | |
| QIB | 50% of the issue size | |
| NIB | 15% of the issue size | |
| Retail Individual Bidders | 35% of the issue size | |
| Offer for Sale | 34,863,635 shares (INR5,194.68 – 5,229.55 crore) |
|
| Fresh Issue | ₹1250 Cr (Expected) | |
| Listing at | NSE & BSE | |
| Apply With | Upstox Free DEMAT Account | |
| Book Running Lead Managers | ||
| Grey Market Price | Gland Pharma IPO GMP Today | |
Gland Pharma IPO Listing
Gland Pharma IPO Review
List of Upcoming IPO in India (NEXT BIG IPOs)
UPCOMING IPO IN NOVEMBER 2020
Gland Pharma IPO GMP Today
Top 5 Multibagger Stocks to buy today
Gland Pharma IPO Dates & Price Band
| IPO Open: | November 9, 2020 |
| IPO Close: | November 11, 2020 |
| IPO Size: | Approx ₹6500 Crores |
| Face Value: | ₹1 Per Equity Share |
| Price Band: | ₹ 1490 – ₹1500 Per Share |
| Listing on: | BSE & NSE |
| Retail Portion: | 35% |
| Total IPO size | 34,863,635 Shares |
Gland Pharma IPO Market Lot:
| Lot Size: | Minimum – 10 Shares & Maximum – 130 Shares |
| Minimum Amount: | ₹15000 |
| Maximum Amount: | ₹195,000 |
Gland Pharma IPO Allotment & Listing Dates:
| Basis of Allotment: | November 17, 2020 |
| Refunds: | November 18, 2020 |
| Credit to Demat Account: | November 19, 2020 |
| Listing Date: | November 20, 2020 |
Objects of the Issue: The bank proposes to utilize the Net Proceeds from the fresh issue offer towards augmenting the Bank’s Tier I capital base to meet the future capital requirement.
Gland Pharma IPO – Promoters
The Promoter of this company is:
- FOSUN PHARMA INDUSTRIAL PTE. LTD
- SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD.
Gland Pharma Financial
On the basis of Standalone statement:
Financials of Gland Pharma IPO:
| Particulars (Cr) | FY18 | FY19 | FY20 |
| Revenue | 1622 | 2044 | 2633 |
| EBITDA | 584 | 792 | 1094 |
| PAT | 321 | 451 | 772 |
Revenue Contributions Country-wise
| Countries | FY18 | FY19 | FY20 |
| USA | 71.25% | 62.50% | 66.74% |
| India | 18.49% | 18.97% | 17.74% |
| Europe | 3.39% | 5.38% | 4.44% |
| Canada | 1.08% | 1.12% | 1.78% |
| Australia | 0.69% | 0.44% | 0.50% |
| Rest of the world | 5.10% | 11.59% | 8.80% |
Gland Pharma IPO [Download DRHP Prospectus]
How to Apply for Gland Pharma IPO?
If you have a Demat account, most banks offer the online IPO application. You can also contact the broker to apply for in MDL ltd IPO? Most banks including the SBI bank, ICICI Bank, Axis, and Kotak bank allow the customer to apply in IPO using the Demat account.
- How to Apply Gland Pharma IPO Through ASBA?
- How to Apply Gland Pharma IPO through Zerodha?
- How to Apply Gland Pharma IPO through SBI Net Banking?
- How to Apply Gland Pharma IPO through HDFC Netbanking?
- ➡️How To Apply Gland Pharma IPO in Axis Bank Net banking?
- ➡️How To Apply Gland Pharma IPO in Kotak Bank Net banking?
How to Check Gland Pharma IPO Allotment?
Check Gland Pharma IPO Allotment Here: 
OR Log on to https://www.linkintime.co.in/IPO/public-issues.html
Note: Gland Pharma IPO Allotment Status will be available whenever the Registrar of IPO will put on their official sites.
# Option 1: BSE Website:
- Go to BSE Website
- Check box “Equity”
- Select IPO Name Gland Pharma
- Type Your Application Number
- Type Your Pan Number
# Option 2: LINKintine Website:
- Go to LINKintime Website
- Select IPO Name Gland Pharma
- Select Option from PAN Number, Application Number or Demat Account Number
- As per selection add PAN Number, Application Number or Demat Account Number
# Option 3: in Your Demat Account:
- Call Your Broker or Login to Your Demat Account / Trading Account
- Check the stock is credited to your account or not
# Option 4: in Your Bank Account:
- Login to your Bank Account
- Check the Amount is debited or released
Gland Pharma IPO Listing Gain
How to Sell Gland Pharma IPO Shares on Listing Day?
Gland Pharma IPO Listing Day Kya kre?
Gland Pharma IPO Lead Managers
| Lead Managers |
|
Gland Pharma IPO Registrar to Offer
| Gland Pharma IPO Registrar |
| Link Intime India Private Limited C-101, 1st Floor 247 Park Lal Bahadur Shastri Marg Vikhroli (West) Mumbai 400 083 Maharashtra, India Tel: +91 22 4918 6200 E-mail: glandpharma.ipo@linkintime.co.in Investor grievance e-mail: glandpharma.ipo@linkintime.co.in Website: www.linkintime.co.in Contact Person: Shanti Gopalkrishnan SEBI Registration No.: INR000004058 |
Other Details:
- Statutory Auditor – S.R. Batliboi & Associates LLP
- Legal Counsel to the Company – Cyril Amarchand Mangaldas
- Bankers to the Company – HDFC Bank Limited, State Bank of India, Canara Bank (e-Syndicate Bank), The Hongkong and Shanghai Banking Corporation Limited and Standard Chartered Bank.
| Company Contact Info: |
|---|
|
Registered Office Gland Pharma Limited Phone: +91-40-30510999 |
| What is IPO? | आईपीओ क्या हैं? आईपीओ का फुल फॉर्म क्या है? |
| Gland Pharma IPO Allotment status |
|---|
Link Intime Website (Click on the below Link)https://linkintime.co.in/MIPO/IPO_App.aspx |
| Upcoming IPO in India 2020 | How to Invest in Share Market? |
| Best Stock Trading Apps 2020 | What are NIFTY and SENSEX? |
| Grey Market Premium of IPO | Intraday Trading Basics |
Final Words
Dear readers, I hope that the above information about “Gland Pharma IPO” has been of great use. If you find the above information useful please share it with others via Facebook and Twitter. You can check more investment researched videos on our YouTube Channel.
SUBSCRIBE YOUTUBE CHANNEL JOIN TELEGRAM CHANNEL for LATEST UPDATESIt is important to be financially literate to make a well-informed investment decision. Stay tuned for more updates. Like, share and subscribe. Drop your comment, queries or feedback in the given below comment box. We would love to hear from you. Thanks and have a nice day.
Gland Pharma IPO FAQs
The Gland Pharma IPO will open in November 9, 2020
The Anchor Investors bidding date is November 8, 2020.
The investors’ portion for QIB-50%, NII-15%, and Retail-35%.
The IPO Size is 6500 Crore with Offer for Sale of 5,229 crores and fresh issue 1250 cr.
Gland Pharma IPO lot size is 10 Shares and the minimum order quantity is 10 Shares.
Gland Pharma IPO lot size is ₹ 1490 – 1500 (Tentative) Equity share and the minimum order quantity is 10 Shares.
Gland Pharma IPO allotment date is November 17, 2020. You can check IPO allotment status here.
Gland Pharma IPO listing date:- The tentative date of Gland Pharma IPO listing is Nov 20, 2020. The IPO to list on NSE and BSE.
You can apply Gland Pharma IPO via ASBA online via your bank account. You can apply ASBA online via UPI through your stock brokers. How to apply IPO through ASBA?
Steps to apply in Gland Pharma IPO through Zerodha
Visit the Zerodha website and login to Console.
Go to Portfolio and click the IPOs link.
Go to the ‘Gland Pharma IPO’ row and click the ‘Bid’ button.
Enter your UPI ID, Quantity, and Price.
‘Submit’ IPO application form.
Visit the UPI App (net banking or BHIM) to approve the mandate.
Visit Zerodha IPO Application Process for more detail.
The Grey Market Premium (GMP) price of Gland Pharma IPO is approx. in between Rs.1500 – 2000/- at the moment.
The Subject to Sauda price for Gland Pharma IPO is approx. Rs. 1000/-